01 1Zhejiang Huahai Pharmaceutical
01 1IRBESARTAN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-29
Pay. Date : 2013-09-24
DMF Number : 21780
Submission : 2008-05-28
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IRBESARTAN USP, with a corresponding US DMF Number 21780.
Remarkably, this DMF maintains an Active status since its submission on May 28, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2013, and payment made on September 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
